151 related articles for article (PubMed ID: 31219614)
21. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration.
Gong W; An Z; Wang Y; Pan X; Fang W; Jiang B; Zhang H
Int J Cancer; 2009 Aug; 125(3):548-55. PubMed ID: 19415746
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry.
Yu C; Tang W; Wang Y; Shen Q; Wang B; Cai C; Meng X; Zou F
Cancer Lett; 2016 Jul; 376(2):268-77. PubMed ID: 27063099
[TBL] [Abstract][Full Text] [Related]
23. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics.
Li YK; Zou J; Ye DM; Zeng Y; Chen CY; Luo GF; Zeng X
Life Sci; 2020 Jan; 241():117113. PubMed ID: 31805288
[TBL] [Abstract][Full Text] [Related]
24. An oncogenic kinase: putting PAK5 forward.
Wen YY; Zheng JN; Pei DS
Expert Opin Ther Targets; 2014 Jul; 18(7):807-15. PubMed ID: 24869804
[TBL] [Abstract][Full Text] [Related]
25. p21-activated kinase 5 inhibits camptothecin-induced apoptosis in colorectal carcinoma cells.
Wang X; Gong W; Qing H; Geng Y; Wang X; Zhang Y; Peng L; Zhang H; Jiang B
Tumour Biol; 2010 Dec; 31(6):575-82. PubMed ID: 20567954
[TBL] [Abstract][Full Text] [Related]
26. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
Ye Y; Tang X; Sun Z; Chen S
Oncotarget; 2016 Apr; 7(14):17854-69. PubMed ID: 26895380
[TBL] [Abstract][Full Text] [Related]
27. Chloride channel ClC-5 binds to aspartyl aminopeptidase to regulate renal albumin endocytosis.
Lee A; Slattery C; Nikolic-Paterson DJ; Hryciw DH; Wilk S; Wilk E; Zhang Y; Valova VA; Robinson PJ; Kelly DJ; Poronnik P
Am J Physiol Renal Physiol; 2015 Apr; 308(7):F784-92. PubMed ID: 25587118
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer.
Wang Y; Zhou L; Lu J; Jiang B; Liu C; Liang Z; Zhou W; Guo J
Exp Cell Res; 2020 Nov; 396(2):112317. PubMed ID: 33038351
[TBL] [Abstract][Full Text] [Related]
29. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.
Han ZX; Wang XX; Zhang SN; Wu JX; Qian HY; Wen YY; Tian H; Pei DS; Zheng JN
Brain Tumor Pathol; 2014 Oct; 31(4):234-41. PubMed ID: 24062079
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
Yan C; Yuan J; Xu J; Zhang G; Li X; Zhang B; Hu T; Huang X; Mao Y; Song G
Med Oncol; 2019 Oct; 36(11):95. PubMed ID: 31637536
[TBL] [Abstract][Full Text] [Related]
32. A Selective Inhibitor of Ubiquitin-Specific Protease 4 Suppresses Colorectal Cancer Progression by Regulating β-Catenin Signaling.
Nguyen HH; Kim T; Nguyen T; Hahn MJ; Yun SI; Kim KK
Cell Physiol Biochem; 2019; 53(1):157-171. PubMed ID: 31251006
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
[TBL] [Abstract][Full Text] [Related]
34. GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling.
Li Y; Ke Q; Shao Y; Zhu G; Li Y; Geng N; Jin F; Li F
Oncotarget; 2015 Feb; 6(6):4345-56. PubMed ID: 25726523
[TBL] [Abstract][Full Text] [Related]
35. Reprogramming an energetic AKT-PAK5 axis boosts axon energy supply and facilitates neuron survival and regeneration after injury and ischemia.
Huang N; Li S; Xie Y; Han Q; Xu XM; Sheng ZH
Curr Biol; 2021 Jul; 31(14):3098-3114.e7. PubMed ID: 34087103
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of novel inhibitors of Mammalian aspartyl aminopeptidase.
Chen Y; Tang H; Seibel W; Papoian R; Oh K; Li X; Zhang J; Golczak M; Palczewski K; Kiser PD
Mol Pharmacol; 2014 Aug; 86(2):231-42. PubMed ID: 24913940
[TBL] [Abstract][Full Text] [Related]
38. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
Hammer A; Diakonova M
BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
[TBL] [Abstract][Full Text] [Related]
39. High expression of P21-activated kinase 5 protein is associated with poor survival in gastric cancer.
Aburatani T; Inokuchi M; Takagi Y; Ishikawa T; Okuno K; Gokita K; Tomii C; Tanioka T; Murase H; Otsuki S; Uetake H; Kojima K; Kawano T
Oncol Lett; 2017 Jul; 14(1):404-410. PubMed ID: 28693183
[TBL] [Abstract][Full Text] [Related]
40. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.
Pan YJ; Wei LL; Wu XJ; Huo FC; Mou J; Pei DS
Cell Death Dis; 2017 Oct; 8(10):e3155. PubMed ID: 29072688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
